Provitro

Provitro is a Berlin-based biotech company that bridges research and development in cell therapy and regenerative medicine. Its core business revolves around distributing primary cells, media, and reagents (notably from ScienCell), and providing a vast repository of human tissue biospecimens for research and target validation. With an ISO 9001-certified quality system and a strong academic partnership, the company focuses on enabling preclinical research through tools and services rather than developing its own therapeutic pipeline.

Integrated research enablement and distribution infrastructure comprising: 1) European distribution network for ScienCell primary cells and reagents, 2) a global biospecimen network and repository of over 3 million human tissue samples, and 3) scientific integration with the Pathological Institute of Charité Universitätsmedizin Berlin for immunohistochemical analysis and expertise.

Provitro competes in two segments: as a distributor, it faces large players like Thermo Fisher and specialized local distributors; in biospecimens, it competes with commercial biobanks and academic tissue banks. Its key differentiator is the combined offering of primary cells + deeply annotated tissues + pathological analysis, backed by a premier academic medical center.